Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
  2. Our Websites |
  3. Global Business Websites |
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce the font size Increase the font size  
Committed to India's health since 1956
A global, integrated healthcare Leader
Your well-being, Our priority
Our key therapeutic areas: Cardiovascular Diseases, Thrombosis, Diabetes, Internal Medicine, Central Nervous System, Oncology, Arthritis and Osteoporosis, Primary Health Care, Vaccines, Consumer Healthcare

    Content :

    An integrated healthcare partner focused on patients' needs

    People are at the heart of everything we do at Sanofi. Through our vaccines, medicines and healthcare solutions, we help prevent and treat those in need.

    Since 1956, Sanofi has aligned itself with India's healthcare needs by building expertise, capability & capacity, through continued investments, strategic partnerships, and a shared commitment towards patients.

    Recent Media Releases

    November 24, 2016

    Sanofi Pasteur launches India’s first 6-in-1 pediatric vaccine – Hexaxim®


    Contact Us


    Sanofi House,
    CTS No.117-B, L&T Business Park,
    Saki Vihar Road, Powai,
    Mumbai 400072

    Tel no. (022) 28032000
    Fax no.(022) 28032846


    Sanofi on YouTube


    Medical Information / Pharmacovigilance

    A key activity of Sanofi is to provide updated medical information on its products, to healthcare professionals, which is in compliance with Indian regulations. All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters.
    For medical information, contact:
    medinfo.india@sanofi.com / Tel no. (022) 28032000 , Extension 2063

    Sanofi also ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide, as pharmacovigilance remains a key activity in the assessment of the therapeutic value of products.
    For Reporting adverse events, contact:
    PV.india@sanofi.com / Tel no. (022) 28032000 , Extension 2055